Steffen Mayerl

1.0k total citations
28 papers, 737 citations indexed

About

Steffen Mayerl is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Molecular Biology. According to data from OpenAlex, Steffen Mayerl has authored 28 papers receiving a total of 737 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Steffen Mayerl's work include Thyroid Disorders and Treatments (21 papers), Growth Hormone and Insulin-like Growth Factors (11 papers) and Genetics and Neurodevelopmental Disorders (9 papers). Steffen Mayerl is often cited by papers focused on Thyroid Disorders and Treatments (21 papers), Growth Hormone and Insulin-like Growth Factors (11 papers) and Genetics and Neurodevelopmental Disorders (9 papers). Steffen Mayerl collaborates with scholars based in Germany, Netherlands and United Kingdom. Steffen Mayerl's co-authors include Heike Heuer, Theo J. Visser, Veerle Darras, Julia Müller, Anita Boelen, Sigrun Horn, Reinhard Bauer, Katrin Buder, Celia M. Kassmann and Charles ffrench‐Constant and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Steffen Mayerl

23 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steffen Mayerl Germany 12 494 185 165 126 105 28 737
Sigrun Horn Germany 9 551 1.1× 208 1.1× 184 1.1× 146 1.2× 152 1.4× 10 841
Carmen Grijota-Martínez Spain 17 635 1.3× 251 1.4× 278 1.7× 166 1.3× 128 1.2× 27 932
Karin Wallis Sweden 13 322 0.7× 121 0.7× 255 1.5× 72 0.6× 51 0.5× 16 709
Marija M. Janjic Serbia 21 329 0.7× 151 0.8× 212 1.3× 138 1.1× 64 0.6× 40 845
Ana Montero‐Pedrazuela Spain 11 291 0.6× 94 0.5× 141 0.9× 48 0.4× 41 0.4× 19 506
Jimena Manzano Spain 8 468 0.9× 156 0.8× 193 1.2× 80 0.6× 84 0.8× 8 666
J H Dussault Canada 12 515 1.0× 147 0.8× 272 1.6× 94 0.7× 141 1.3× 19 952
Hideo Yoshizato Japan 11 236 0.5× 82 0.4× 138 0.8× 63 0.5× 20 0.2× 26 479
Sandra Zárate Argentina 13 142 0.3× 105 0.6× 172 1.0× 28 0.2× 23 0.2× 19 547
Camila Scorticati Argentina 14 92 0.2× 131 0.7× 222 1.3× 58 0.5× 30 0.3× 28 709

Countries citing papers authored by Steffen Mayerl

Since Specialization
Citations

This map shows the geographic impact of Steffen Mayerl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffen Mayerl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffen Mayerl more than expected).

Fields of papers citing papers by Steffen Mayerl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steffen Mayerl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffen Mayerl. The network helps show where Steffen Mayerl may publish in the future.

Co-authorship network of co-authors of Steffen Mayerl

This figure shows the co-authorship network connecting the top 25 collaborators of Steffen Mayerl. A scholar is included among the top collaborators of Steffen Mayerl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steffen Mayerl. Steffen Mayerl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ullrich, Daniel, Dagmar Führer, Heike Heuer, et al.. (2025). Triiodothyronine treatment in mice improves stroke outcome and reduces blood–brain barrier damage. European Thyroid Journal. 14(1).
3.
4.
5.
Markova, Boyka, Steffen Mayerl, & Heike Heuer. (2024). Toward a treatment for thyroid hormone transporter MCT8 deficiency – achievements and challenges. European Thyroid Journal. 13(6).
6.
Mayerl, Steffen, et al.. (2024). Thyroid hormone action in adult neurogliogenic niches: the known and unknown. Frontiers in Endocrinology. 15. 1347802–1347802. 4 indexed citations
7.
Vancamp, Pieter, Boyka Markova, Olga Shevchuk, et al.. (2023). Proteome Analysis of Thyroid Hormone Transporter Mct8/Oatp1c1-Deficient Mice Reveals Novel Dysregulated Target Molecules Involved in Locomotor Function. Cells. 12(20). 2487–2487. 3 indexed citations
8.
Mayerl, Steffen, et al.. (2023). Local Thyroid Hormone Action in Brain Development. International Journal of Molecular Sciences. 24(15). 12352–12352. 22 indexed citations
9.
Mayerl, Steffen & Heike Heuer. (2023). Thyroid hormone transporter Mct8/Oatp1c1 deficiency compromises proper oligodendrocyte maturation in the mouse CNS. Neurobiology of Disease. 184. 106195–106195. 6 indexed citations
10.
Chen, Jiesi, Lutz Liebmann, Sivaraj Mohana Sundaram, et al.. (2023). Triac Treatment Prevents Neurodevelopmental and Locomotor Impairments in Thyroid Hormone Transporter Mct8/Oatp1c1 Deficient Mice. International Journal of Molecular Sciences. 24(4). 3452–3452. 6 indexed citations
11.
Stewart, Michelle, Gemma Codner, Steffen Mayerl, et al.. (2022). An animal model for Pierpont syndrome: a mouse bearing the Tbl1xr1 Y446C/Y446C mutation. Human Molecular Genetics. 31(17). 2951–2963. 8 indexed citations
12.
Reinwald, Jonathan, Wolfgang Weber‐Fahr, Alejandro Cosa‐Linan, et al.. (2022). TRIAC Treatment Improves Impaired Brain Network Function and White Matter Loss in Thyroid Hormone Transporter Mct8/Oatp1c1 Deficient Mice. International Journal of Molecular Sciences. 23(24). 15547–15547. 13 indexed citations
13.
Mayerl, Steffen, Elena Tsourdi, François Verrey, et al.. (2021). The Thyroid Hormone Transporter MCT10 Is a Novel Regulator of Trabecular Bone Mass and Bone Turnover in Male Mice. Endocrinology. 163(1). 6 indexed citations
14.
Mayerl, Steffen & Charles ffrench‐Constant. (2021). Establishing an Adult Mouse Brain Hippocampal Organotypic Slice Culture System that Allows for Tracing and Pharmacological Manipulation of ex vivo Neurogenesis. BIO-PROTOCOL. 11(1). e3869–e3869. 4 indexed citations
15.
Mayerl, Steffen, Heike Heuer, & Charles ffrench‐Constant. (2020). Hippocampal Neurogenesis Requires Cell-Autonomous Thyroid Hormone Signaling. Stem Cell Reports. 14(5). 845–860. 22 indexed citations
16.
Mayerl, Steffen, et al.. (2019). Tissue-Specific Function of Thyroid Hormone Transporters: New Insights from Mouse Models. Experimental and Clinical Endocrinology & Diabetes. 128(06/07). 423–427. 5 indexed citations
17.
Mayerl, Steffen, Manuel Schmidt, Veerle Darras, et al.. (2018). Thyroid Hormone Transporters MCT8 and OATP1C1 Control Skeletal Muscle Regeneration. Stem Cell Reports. 10(6). 1959–1974. 28 indexed citations
18.
Zoch, Ansgar, Steffen Mayerl, Alexander Schulz, et al.. (2015). Merlin Isoforms 1 and 2 Both Act as Tumour Suppressors and Are Required for Optimal Sperm Maturation. PLoS ONE. 10(8). e0129151–e0129151. 13 indexed citations
19.
Mayerl, Steffen, Julia Müller, Reinhard Bauer, et al.. (2014). Transporters MCT8 and OATP1C1 maintain murine brain thyroid hormone homeostasis. Journal of Clinical Investigation. 124(5). 1987–1999. 221 indexed citations
20.
Schnell, Christian, Sven P. Wichert, Steffen Mayerl, et al.. (2013). The multispecific thyroid hormone transporter OATP1C1 mediates cell-specific sulforhodamine 101-labeling of hippocampal astrocytes. Brain Structure and Function. 220(1). 193–203. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sigrun Horn Breakdown of academic impact, for papers by Carmen Grijota-Martínez Breakdown of academic impact, for papers by Karin Wallis Breakdown of academic impact, for papers by Marija M. Janjic Breakdown of academic impact, for papers by Ana Montero‐Pedrazuela Breakdown of academic impact, for papers by Jimena Manzano Breakdown of academic impact, for papers by J H Dussault Breakdown of academic impact, for papers by Hideo Yoshizato Breakdown of academic impact, for papers by Sandra Zárate Breakdown of academic impact, for papers by Camila Scorticati
Rankless by CCL
2026